BlogHeader.png

Need to Know: Details About Alcami's New St. Louis, MO Facility

You've probably heard by now that our St. Louis, MO site is relocating. The current Alcami St. Louis facility for laboratory operations will be transitioning to a new building being constructed at the following location:


4260 Forest Park Avenue
Suite 201
St. Louis, MO 63108

Read on to see what we have planned for our new state-of-the-art facility!

Topics: Company News

Alcami Donates Life-Saving LUCAS® 3 Chest Compression System to Germantown, WI Fire Department

Germantown, WI – January 31, 2017 – Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces the donation of a Physio-Control LUCAS® 3 Chest Compression System, an electrically powered, portable life-saving medical device that facilitates the return of spontaneous circulation in cardiac arrest patients, to the Germantown Fire Department. Alcami operates a world-class Active Pharmaceutical Ingredient (API) manufacturing and development facility in Germantown, Wisconsin.

Topics: Company News

Have you Heard? Alcami’s St. Louis, MO Site is Moving!

Alcami is on the move! In February 2016, Alcami announced the investment of over ten million dollars in a new facility for their St. Louis, Missouri location.

The new facility will be located in the Cortex Innovation Center in the newly revived historic area of the Central West End. The Cortex Center is home to bioscience, development, and technology research organizations, including a number of startup programs. Alcami will occupy the top two floors of a building shared with Techshop, a community-based workshop.

Topics: Company News

Dr. Stephan Kutzer, Alcami CEO & President, Appointed to DCAT Board of Directors

Alcami is pleased to announce the appointment of Dr. Stephan Kutzer, Alcami CEO & President, to serve on the Board of Directors for the Drug, Chemical & Associated Technologies Association (DCAT).  The new Board of Directors and Advisory Council were announced on November 1, 2016 naming Dr. Kutzer as the elected Third Vice President.  It is the role of the board to work on developing and guiding the organization's strategic plan, establishing and implementing policy, and managing financial matters for member companies.

DCAT is an industry organization that powers relationships and industry knowledge for companies engaged in the business of pharmaceutical development and manufacturing.

Topics: Company News

Alcami Announces Innovative Protect Your Brand™ Offering to Secure Your Supply Chain

Wilmington, NC – October 04, 2016 – Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces its first to market Protect Your Brand™ offering to support companies interested in implementing a back up supply option. Under this program, Alcami will initiate tech transfer within a month of inquiry and execute a customized, phase appropriate qualification plan in advance of potential manufacturing needs without any long-term commitment or annual purchase obligation. It’s that simple. This industry leading offering can be used for small molecule drug substance and / or small molecule and biologics drug product in support of clinical, launch and commercial supply.

Topics: Company News

Alcami Announces Enhanced Analytical Services in Edison, New Jersey

Wilmington, NC - September 22, 2016 - Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces strengthened capabilities in analytical services at its Edison, New Jersey site.

Topics: Company News

Alcami Announces Completion of Site Investment and Expansion in Drug Product Manufacturing and Development Facilities

Wilmington, NC - September 8, 2016 - Alcami Corporation, a leading provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, today announces additional laboratory-scale capabilities to support prefilled syringes in Wilmington, NC and the successful completion of previously announced investments in Charleston, SC.

Topics: Company News

Alcami Announces New Highly Potent API Capabilities and Capacity in Germantown, WI

Wilmington, NC – August 11, 2016 – Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces its plans to expand capabilities for development and manufacturing of Active Pharmaceutical Ingredients (APIs) at its Germantown, WI facility.

Topics: Company News

St. Louis Relocation Newsletter

Wilmington, NC – July 25, 2016 – We are pleased to announce the opening of a new world-class laboratory facility in St. Louis. The current site for laboratory operations will be transitioning to a new building located in the Cortex Innovation Center at 4320 Forest Park Ave., Suite 201, St. Louis, MO 63108. 

In order to keep our clients and potential customers updated on the development of the St. Louis relocation, we have created a quarterly newsletter that includes an overview of the relocation, design details, a milestone schedule, growth plan, and more. You can view the newsletter here

Topics: Company News

St. Louis Relocation Regulatory Change Notification

Wilmington, NC – July 25, 2016 – In February, 2016, Alcami, formerly AAIPharma Services Corp./ Cambridge Major Laboratories, announced planned investment of at least $10.7 Million to relocate its St. Louis, MO analytical testing facility to the Cortex Innovation Center.

Following the announcement, a formal Regulatory Change Notification Letter was sent to individuals who work, or have worked, with the Alcami St. Louis site. 

You can read the full Regulatory Change Notification Letter here to learn more about the relocation. 

Topics: Company News